Biotech Values

[ghmm]

ALTU -

Pre_Clinical,

I like them and recently became a shareholder and have been building a position. I am not a day-to-day trader so I can't say when the bottom is. I like the "value" involved. Aside from their two Phase 3 programs which derive most of the value, I really like their pre-clinical candidates especially ALTU-237 not even the larger kidney-stone indication. I think Primary hyperoxaluria and enteric hyperoxaluria could end up being a very valuable indications in and of themselves and suspect its development will be very fast.

I really like the management backgrounds. Good to see several TKT people. Interestingly their "manufacturing" (ended up not being mfg related) issues resulted in hiring the former TKT head of manufacturing which if I recall correctly Michael Astrue gave very glowing praise to on several occasions.

Not to mention the cash is more then half the stock price.

If I were to suspect on the decline (outside of someone wanting to sell and the float not being too high). I could think of a couple things:
1-Eurand is presenting info on their Pancreatic Insufficiency product (perhaps some people are thinking they'll get more of the market)
2-No word on Genentech x-US partnership for a couple months. And trial didn't start yet or get update on when it will.
3-Dr. Falk Pharma dispute and the potential patent issue.
3-